Alcohol and HCV Chronic Infection Are Risk Cofactors of Type 2 Diabetes Mellitus for Hepatocellular Carcinoma in Italy

被引:26
|
作者
Balbi, Massimiliano [1 ]
Donadon, Valter [1 ]
Ghersetti, Michela [1 ]
Grazioli, Silvia [1 ]
Della Valentina, Giovanni [1 ]
Gardenal, Rita [1 ]
Dal Mas, Maria [1 ]
Casarin, Pietro [1 ]
Zanette, Giorgio [2 ]
Miranda, Cesare [2 ]
Cimarosti, Paolo [3 ]
机构
[1] Pordenone Hosp, Dept Med, I-33170 Pordenone, Italy
[2] Pordenone Hosp, Diabet Clin, I-33170 Pordenone, Italy
[3] Pordenone Hosp, Community Addict Serv, I-33170 Pordenone, Italy
关键词
Hepatocellular carcinoma; Type 2 diabetes mellitus; HCV infections; alcohol abuse; CHRONIC LIVER-DISEASE; OXIDATIVE STRESS; VIRAL-HEPATITIS; UNITED-STATES; CANCER; COMPLICATIONS; CONSUMPTION; POPULATION; MORTALITY; COHORT;
D O I
10.3390/ijerph7041366
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Type 2 diabetes mellitus (DM2) has been associated with hepatocellular carcinoma (HCC) development. To study this relationship, we enrolled 465 HCC patients compared with 618 Cirrhotic cases and 490 Controls. The prevalence of DM2 is significantly higher in HCC patients with an Odds Ratio of 3.12 versus Controls. In HCC cases with alcohol abuse, the frequency of DM2 is the highest. In our HCC patients, when HCV infection is associated with alcohol abuse, the liver cancer develops earlier. In addition, multivariate analysis shows that alcohol consumption is an independent risk factor for HCC more relevant than HCV infection.
引用
收藏
页码:1366 / 1378
页数:13
相关论文
共 50 条
  • [31] Type 2 Diabetes Mellitus and Increased Risk for Malaria Infection
    Danquah, Ina
    Bedu-Addo, George
    Mockenhaupt, Frank P.
    EMERGING INFECTIOUS DISEASES, 2010, 16 (10) : 1601 - 1604
  • [32] The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma
    Polesel, J.
    Zucchetto, A.
    Montella, M.
    Dal Maso, L.
    Crispo, A.
    La Vecchia, C.
    Serraino, D.
    Franceschi, S.
    Talamini, R.
    ANNALS OF ONCOLOGY, 2009, 20 (02) : 353 - 357
  • [33] Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C
    Arase, Yasuji
    Kobayashi, Mariko
    Suzuki, Fumitaka
    Suzuki, Yoshiyuki
    Kawamura, Yusuke
    Akuta, Norio
    Kobayashi, Masahiro
    Sezaki, Hitomi
    Saito, Satoshi
    Hosaka, Tetsuya
    Ikeda, Kenji
    Kumada, Hiromitsu
    Kobayashi, Tetsuro
    HEPATOLOGY, 2013, 57 (03) : 964 - 973
  • [34] Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis
    P. Wainwright
    E. Scorletti
    C. D. Byrne
    Current Diabetes Reports, 2017, 17
  • [35] Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis
    Wainwright, P.
    Scorletti, E.
    Byrne, C. D.
    CURRENT DIABETES REPORTS, 2017, 17 (04)
  • [36] Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes
    Tseng, Chin-Hsiao
    LIVER INTERNATIONAL, 2018, 38 (11) : 2018 - 2027
  • [37] NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes
    Bugianesi E.
    Vanni E.
    Marchesini G.
    Current Diabetes Reports, 2007, 7 (3) : 175 - 180
  • [38] TYPE 2 DIABETES MELLITUS AND LACK OF HEPATIC FIBROSIS REGRESSION ARE ASSOCIATED WITH INCREASED HEPATOCELLULAR CARCINOMA INCIDENCE AFTER HCV CURE
    Talat, Arslan
    Chen, Hao Wei
    Kaur, Satinder Pal
    Lau, Daryl
    HEPATOLOGY, 2020, 72 : 615A - 615A
  • [39] Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis
    Man-Yu Li
    Ting-Ting Li
    Ke-Jian Li
    Cheng Zhou
    World Journal of Clinical Cases, 2023, (05) : 1009 - 1018
  • [40] Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis
    Li, Man-Yu
    Li, Ting-Ting
    Li, Ke-Jian
    Zhou, Cheng
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (05) : 1009 - 1018